Xcenda, Palm Harbor, Fla.
Sanofi US, Bridgewater, NJ.
J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):595-601.e1. doi: 10.1016/j.jaip.2013.07.003. Epub 2013 Sep 8.
Food-induced anaphylaxis is a potentially life-threatening condition that frequently results in emergency department (ED) visits and/or hospitalization. Little information is available on patient compliance with recommended postdischarge anaphylaxis care.
To describe patient characteristics, concordance with recommended postdischarge care, and risk of repeated events among adults with an initial ED visit and/or hospitalization for food-induced anaphylaxis.
In this retrospective study of health care claims, adults with an ED visit and/or hospitalization for food-induced anaphylaxis were identified from the 2002-2008 Truven Health MarketScan Databases by using an expanded International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code algorithm. The first identified ED visit and/or hospitalization was the index event. Data from patients with continuous medical and prescription coverage for ≥1 year before and after the index event were retained for analysis. Analyses included baseline demographic and clinical characteristics, postdischarge epinephrine autoinjector (EAI) prescription fills and allergist/immunologist visits, and repeated events in the 1-year postindex period.
Patients (n = 1370) had a mean (SD) age of 44 ± 15 years, 58% were women. Most (86%) were seen in the ED and/ discharged from the ED. Within 1 year after discharge, 54% of adults had filled ≥1 EAI prescription (71% within 1 week) and 22% had ≥1 allergist/immunologist visit (53% within 4 weeks). Overall, 73 patients (5%) had evidence of a subsequent anaphylaxis-related ED visit and/or hospitalization 1 year after discharge.
Concordance with recommended postdischarge anaphylaxis care was low among adults with food-induced anaphylaxis. Within 1 year after discharge, 54% of patients filled an EAI prescription and 22% consulted an allergist/immunologist.
食物诱发的过敏反应是一种潜在的危及生命的疾病,常导致急诊就诊和/或住院。关于患者对出院后过敏反应护理的建议的依从性,目前知之甚少。
描述首次因食物诱发的过敏反应而急诊就诊和/或住院的成年人的患者特征、与推荐的出院后护理的一致性以及再次发生过敏反应的风险。
在这项回顾性医疗索赔研究中,通过使用扩展的国际疾病分类第 9 版临床修正诊断代码算法,从 2002 年至 2008 年 Truven Health MarketScan 数据库中确定了因食物诱发的过敏反应而急诊就诊和/或住院的成年人。首次确定的急诊就诊和/或住院为指数事件。保留索引事件前和后≥1 年有持续医疗和处方覆盖的患者数据进行分析。分析包括基线人口统计学和临床特征、出院后肾上腺素自动注射器(EAI)处方填写情况和过敏症/免疫学家就诊情况,以及索引后 1 年内的再次发生事件。
患者(n=1370)的平均(SD)年龄为 44±15 岁,58%为女性。大多数(86%)患者在急诊就诊并/或从急诊室出院。出院后 1 年内,54%的成年人至少填写了 1 份 EAI 处方(71%在 1 周内),22%至少就诊过 1 次过敏症/免疫学家(53%在 4 周内)。总体而言,73 名患者(5%)在出院后 1 年内有证据表明发生了与过敏反应相关的再次急诊就诊和/或住院。
食物诱发的过敏反应成年人中,建议的出院后过敏反应护理的依从性较低。出院后 1 年内,54%的患者填写了 EAI 处方,22%的患者咨询了过敏症/免疫学家。